X-48904691-TC-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 4P and 4B. PVS1_StrongBS2
The ENST00000445167.7(SLC35A2):βc.627delβ(p.Thr210LeufsTer42) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000105 in 1,206,652 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 47 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (β ).
Frequency
Genomes: π 0.000054 ( 0 hom., 2 hem., cov: 23)
Exomes π: 0.00011 ( 0 hom. 45 hem. )
Consequence
SLC35A2
ENST00000445167.7 frameshift
ENST00000445167.7 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.600
Genes affected
SLC35A2 (HGNC:11022): (solute carrier family 35 member A2) This gene encodes a member of the nucleotide-sugar transporter family. The encoded protein is a multi-pass membrane protein. It transports UDP-galactose from the cytosol into Golgi vesicles, where it serves as a glycosyl donor for the generation of glycans. Mutations in this gene cause congenital disorder of glycosylation type IIm (CDG2M). Multiple alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Oct 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. There are 5 pathogenic variants in the truncated region.
BS2
High Hemizygotes in GnomAd4 at 2 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC35A2 | NM_005660.3 | c.1163+54del | intron_variant | ENST00000247138.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC35A2 | ENST00000247138.11 | c.1163+54del | intron_variant | 1 | NM_005660.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000542 AC: 6AN: 110746Hom.: 0 Cov.: 23 AF XY: 0.0000604 AC XY: 2AN XY: 33134
GnomAD3 genomes
AF:
AC:
6
AN:
110746
Hom.:
Cov.:
23
AF XY:
AC XY:
2
AN XY:
33134
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000111 AC: 2AN: 179919Hom.: 0 AF XY: 0.0000154 AC XY: 1AN XY: 64743
GnomAD3 exomes
AF:
AC:
2
AN:
179919
Hom.:
AF XY:
AC XY:
1
AN XY:
64743
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000110 AC: 121AN: 1095906Hom.: 0 Cov.: 31 AF XY: 0.000125 AC XY: 45AN XY: 361382
GnomAD4 exome
AF:
AC:
121
AN:
1095906
Hom.:
Cov.:
31
AF XY:
AC XY:
45
AN XY:
361382
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000542 AC: 6AN: 110746Hom.: 0 Cov.: 23 AF XY: 0.0000604 AC XY: 2AN XY: 33134
GnomAD4 genome
AF:
AC:
6
AN:
110746
Hom.:
Cov.:
23
AF XY:
AC XY:
2
AN XY:
33134
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jan 31, 2023 | Variant summary: SLC35A2 c.1163+54delG is located at a position not widely known to affect splicing. 4/4 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. This variant is also annotated in alternate transcripts for this gene as NM_001032289.3:c.627delG in the last exon (exon 4) and as NM_001042498.3:c.*35delG in the downstream 3' untranslated region (UTR). To our knowledge truncations downstream of exon 4 in the transcript NM_001032289.3 have not been reported in individuals affected with SLC35A2-Congenital Disorder Of Glycosylation. The variant allele was found at a frequency of 1.1e-05 in 179919 control chromosomes in gnomAD exomes and 0.93e-05 in 21356 control chromosomes in gnomAD exomes plus genomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.1163+54delG or alternate annotations of this variant, in individuals affected with SLC35A2-Congenital Disorder Of Glycosylation and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at